Humanigen Inc (HGENQ)

[DonDonDonDon]

The share price not increasing yesterday was frustrating. But the new variant news did come out on Tuesday and the share price went up nicely on Wednesday. It still would have been nice to get back to $7 yesterday. But buyers will come in over the next weeks when they research Omicron and seek variant agnostic therapeutics to invest in. Variant agnostic therapeutics will be here as long as Covid evolves which might be forever.

The US FDA and MHRA are well aware that lenz is variant agnostic. The Omicron variant definitely improves lenz's chances at getting an authorization in both countries. The US FDA took over 100 days to decide on lenz's original EUA application. They were likely on the fence. Hard to imagine that they don't give the EUA soon if they were indeed on the fence in September.